Grants per year
Personal profile
Research Interests
Practice focused on diagnosis and comprehensive treatment of multiple sclerosis and related CNS demyelinating diseases. Research interests focused on novel clinical therapeutics for Multiple Sclerosis and related CNS Demyelinating diseases.
Certifications and Licenses
| Internal Medicine | |
| Neurology |
Training Experience
| 1981 | Residency, Lutheran General Hospital |
| 1984 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
Medicine, MD, University of Illinois at Chicago
… → 1978
Research interests keywords
- Autoimmune Diseases
- Multiple Sclerosis
Fingerprint
Dive into the research topics where Bruce Arnold Cohen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Intermittent Hypoxia Initiated Motor Plasticity in Individuals with Multiple Sclerosis
Bright, M. (PD/PI), Cohen, B. A. (Co-Investigator) & Nemeth, A. J. (Co-Investigator)
Rehabilitation Institute of Chicago, National Institute of Child Health and Human Development
9/4/23 → 8/31/25
Project: Research project
-
Prot # WA21092/B: A Randomized, Double-blind, Double Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a(Rebif®)in Patients with Relapsing Multiple Sclerosis
Cohen, B. A. (PD/PI)
Quintiles, Inc., Genentech, Inc
3/23/12 → 2/1/25
Project: Research project
-
Sprint-MS-2 Project
Cohen, B. A. (PD/PI)
Cleveland Clinic Foundation, National Multiple Sclerosis Society
9/1/23 → 9/30/24
Project: Research project
-
Prot# ALXN1210-NMO-307: A Phase 3, External Placebo-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Cohen, B. A. (PD/PI)
INC Research, LLC, Alexion Pharmaceuticals, Inc
2/18/21 → 2/17/22
Project: Research project
-
Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: A practical review
Coyle, P. K., Freedman, M. S., Cohen, B. A., Cree, B. A. C. & Markowitz, C. E., Apr 2024, In: Annals of clinical and translational neurology. 11, 4, p. 842-855 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
Differential Diagnosis of Tumor-like Brain Lesions
Perez Giraldo, G. S., Singer, L., Cao, T., Jamshidi, P., Dixit, K., Kontzialis, M., Castellani, R., Pytel, P., Anadani, N., Bevan, C. J., Grebenciucova, E., Balabanov, R., Cohen, B. A. & Graham, E. L., Oct 30 2023, In: Neurology: Clinical Practice. 13, 5, e200182.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society
Miller, A. E., Chitnis, T., Cohen, B. A., Costello, K., Sicotte, N. L. & Stacom, R., Feb 2021, In: JAMA Neurology. 78, 2, p. 241-246 6 p.Research output: Contribution to journal › Review article › peer-review
41 Scopus citations -
Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study
on behalf of the SPRINT-MS investigators, Jan 26 2021, In: Neurology. 96, 4, p. E491-E500Research output: Contribution to journal › Article › peer-review
Open Access31 Scopus citations -
Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS
Freedman, M. S., Brod, S., Singer, B. A., Cohen, B. A., Hayward, B., Dangond, F. & Coyle, P. K., Jan 1 2020, In: Journal of Neurology. 267, 1, p. 64-75 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations